Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412
dc.contributor.author | Ao, Zhujun | |
dc.contributor.author | Zhu, Rong | |
dc.contributor.author | Tan, Xiaoli | |
dc.contributor.author | Liu, Lisa | |
dc.contributor.author | Chen, Liyu | |
dc.contributor.author | Liu, Shuiping | |
dc.contributor.author | Yao, XiaoJian | |
dc.date.accessioned | 2016-10-21T13:59:28Z | |
dc.date.available | 2016-10-21T13:59:28Z | |
dc.date.issued | 2016-10-21 | |
dc.date.updated | 2016-10-21T06:03:09Z | |
dc.description.abstract | Abstract Background HIV-1 latency is a major obstacle for HIV-1 eradication. Extensive efforts are being directed toward the reactivation of latent HIV reservoirs with the aim of eliminating latently infected cells via the host immune system and/or virus-mediated cell lysis. Results We screened over 1,500 small molecules and kinase inhibitors and found that a small molecule, PKC412 (midostaurin, a broad-spectrum kinase inhibitor), can stimulate viral transcription and expression from the HIV-1 latently infected ACH2 cell line and primary resting CD4+ T cells. PKC412 reactivated HIV-1 expression in ACH2 cells in a dose- and time-dependent manner. Our results also suggest that the nuclear factor κB (NF-κB) signaling could be one of cellular pathways activated during PKC412-mediated activation of latent HIV-1 expression. Additionally, combining PKC412 with the HDAC inhibitor vorinostat (VOR) had an additive effect on HIV-1 reactivation in both ACH2 cells and infected resting CD4+ T cells. Conclusions These studies provide evidence that PKC412 is a new compound with the potential for optimization as a latency-reactivator to eradicate HIV-1 infection. | |
dc.identifier.citation | Virology Journal. 2016 Oct 21;13(1):177 | |
dc.identifier.uri | http://dx.doi.org/10.1186/s12985-016-0637-9 | |
dc.identifier.uri | http://hdl.handle.net/1993/31897 | |
dc.language.rfc3066 | en | |
dc.rights | open access | en_US |
dc.rights.holder | The Author(s). | |
dc.title | Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412 | |
dc.type | Journal Article |